Skip to main content

Principal Financial Group Inc

Source: SEC Form 13F · as of Mar 2026

Principal Financial Group Inc holds 70 biotech & pharma companies tracked by BioSniper, totaling $1.39B in value as of Mar 2026 (SEC Form 13F).

Companies held

70

Total value held

$1.39B

BioSniper AIPage evidence connected

Prepared research question

What matters most for GILEAD SCIENCES, INC. (GILD)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
GILDGILEAD SCIENCES, INC.1,769,886$246.7M
INSMINSMED Inc916,464$149.9M
BBIOBridgeBio Pharma, Inc.1,330,415$98.8M
REGNREGENERON PHARMACEUTICALS, INC.120,425$93.0M
GPCRStructure Therapeutics Inc.1,753,764$84.5M
CYTKCYTOKINETICS INC1,093,485$72.1M
AXSMAxsome Therapeutics, Inc.350,488$59.2M
PTGXProtagonist Therapeutics, Inc367,822$38.8M
PTCTPTC THERAPEUTICS, INC.515,001$35.1M
ABVXAbivax SA312,274$34.8M
ARWRARROWHEAD PHARMACEUTICALS, INC.490,122$30.7M
DNLIDenali Therapeutics Inc.1,478,486$28.4M
ROIVRoivant Sciences Ltd.1,005,533$27.9M
JAZZJazz Pharmaceuticals plc135,504$25.6M
EXELEXELIXIS, INC.583,744$25.0M
BMRNBIOMARIN PHARMACEUTICAL INC428,607$24.2M
ADPTAdaptive Biotechnologies Corp1,704,887$23.7M
ALMSALUMIS INC.1,058,051$23.3M
TGTXTG THERAPEUTICS, INC.665,526$22.1M
INCYIncyte Corp.225,492$21.2M
APLSApellis Pharmaceuticals, Inc.499,053$20.1M
MRNAModerna, Inc.387,718$19.7M
LGNDLigand Pharmaceuticals Incorporated95,716$19.1M
SUPNSUPERNUS PHARMACEUTICALS, INC.341,117$17.6M
ACADACADIA PHARMACEUTICALS INC768,224$17.1M
VKTXViking Therapeutics, Inc.525,484$17.1M
IMCRImmunocore Holdings plc519,130$15.7M
ADMAADMA BIOLOGICS, INC.1,390,313$12.5M
ANIPANI PHARMACEUTICALS INC129,148$9.9M
INVAInnoviva, Inc.418,731$9.8M
RCUSArcus Biosciences, Inc.413,778$8.9M
VCELVericel Corp247,324$8.0M
FOLDAMICUS THERAPEUTICS, INC.529,407$7.7M
OGNOrganon & Co.1,260,689$7.6M
BCYCBICYCLE THERAPEUTICS PLC1,174,625$5.5M
ARQTArcutis Biotherapeutics, Inc.168,826$4.0M
COGTCogent Biosciences, Inc.83,944$3.2M
TEVATeva Pharmaceutical Industries Limited97,269$2.9M
STOKStoke Therapeutics, Inc.63,933$2.1M
ZYMEZymeworks Inc.78,547$2.0M
ARGXARGENX SE2,675$2.0M
ALNYALNYLAM PHARMACEUTICALS, INC.5,649$1.9M
HROWHARROW, INC.51,869$1.8M
VRDNViridian Therapeutics, Inc.\DE75,200$1.5M
XERSXeris Biopharma Holdings, Inc.208,507$1.2M
ESPREsperion Therapeutics, Inc.422,776$1.2M
KROSKeros Therapeutics, Inc.59,594$658K
IONSIONIS PHARMACEUTICALS INC7,019$527K
RYTMRHYTHM PHARMACEUTICALS, INC.5,637$490K
RVMDREVOLUTION MEDICINES, INC.4,567$444K
NUVLNuvalent, Inc.3,610$370K
PCVXVaxcyte, Inc.5,275$307K
SRRKScholar Rock Holding Corp6,113$301K
APGEApogee Therapeutics, Inc.3,221$271K
SYRESpyre Therapeutics, Inc.4,299$217K
TERNTerns Pharmaceuticals, Inc.4,064$214K
IBRXImmunityBio, Inc.19,710$151K
DRTSAlpha Tau Medical Ltd.18,677$132K
OCULOCULAR THERAPEUTIX, INC13,623$115K
ARDXARDELYX, INC.17,570$105K
RXRXRECURSION PHARMACEUTICALS, INC.33,161$102K
GERNGERON CORP39,519$59K
SVRASavara Inc10,358$57K
SLSSELLAS Life Sciences Group, Inc.12,429$53K
IOVAIOVANCE BIOTHERAPEUTICS, INC.14,329$50K
PGENPRECIGEN, INC.12,844$50K
ABUSArbutus Biopharma Corp10,977$49K
NUVBNuvation Bio Inc.11,230$48K
ABSIAbsci Corporation10,296$31K
OPKOPKO HEALTH, INC.17,740$20K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.